Table 5 Association of SNPs in the HLA region with PBC in the absence of major HLA factors identified in this study.
Population | Number of individuals | SNPs with p < 5 × 10−8 | Odds ratio (95% CI), p | |||
|---|---|---|---|---|---|---|
Patients | Controls | rs9268644* | rs9275175† | rs9277509§ | ||
All | ||||||
1200 | 1196 | 305/4103 | 0.39 (0.33–0.47), p = 5.64 × 10 −24 | 0.41 (0.33–0.50), p = 6.06 × 10−18 | 0.55 (0.46–0.65), p = 1.63 × 10−12 | |
DQB1*06:04 –negative | ||||||
1163 | 1025 | 62/4103 | 0.52 (0.43–0.64), p = 3.69 × 10−10 | 0.46 (0.36–0.58), p = 8.71 × 10−12 | 0.63 (0.53–0.75), p = 1.91 × 10−7 | |
DRB1*08:03 –negative | ||||||
917 | 1017 | 361/4103 | 0.42 (0.34–0.51), p = 1.70 × 10−18 | 0.44 (0.36–0.55), p = 5.76 × 10−14 | 0.51 (0.42–0.61), p = 5.78 × 10−13 | |
DQB1*03:01 –negative | ||||||
1056 | 940 | 333/4103 | 0.41 (0.33–0.51), p = 3.45 × 10−17 | 0.43 (0.34–0.56), p = 1.56 × 10−11 | 0.54 (0.45–0.65), p = 5.45 × 10−11 | |
DQB1*04:01 –negative | ||||||
822 | 916 | 251/4103 | 0.41 (0.33–0.50), p = 1.04 × 10−17 | 0.43 (0.34–0.53), p = 1.31 × 10−14 | 0.49 (0.40–0.60), p = 2.05 × 10−12 | |
DQB1*06:04 -negative, DQB1*03:01 –negative | ||||||
1020 | 790 | 3/4103 | 0.65 (0.51–0.83), p = 0.00054 | 0.54 (0.41–0.71), p = 6.90 × 10−6 | 0.65 (0.53–0.78), p = 6.87 × 10−6 | |
DRB1*08:03 -negative, DQB1*04:01 –negative | ||||||
594 | 763 | 225/4103 | 0.45 (0.35–0.56), p = 2.13 × 10−12 | 0.48 (0.38–0.61), p = 5.04 × 10−10 | 0.45 (0.36–0.57), p = 3.46 × 10−12 | |
DQB1*06:04 -negative, DRB1*08:03 -negative, DQB1*03:01 -negative, DQB1*04:01 -negative | ||||||
476 | 440 | 0/4103 | 0.79 (0.59–1.07), p = 0.13 | 0.62 (0.46–0.83), p = 0.0013 | 0.49 (0.37–0.65), p = 2.30 × 10 −7 | |